Abstract | PURPOSE: Perinatal outcomes were compared before and after changes in the treatment policy to improve the management for preterm PROM ( pPROM). METHODS: This is a retrospective analysis of 99 cases of pPROM diagnosed between 27 and 34 weeks of gestation, which were managed according to the following two different protocols. Group A (47 cases): tocolytic therapy was continued to prevent preterm delivery until clinical chorioamnionitis (CAM) was diagnosed between January 2000 and June 2004. Group B (52 cases): labor was induced or cesarean section performed when oligohydramnios was diagnosed and/or elevation elastase (EL) of amnion was detected by amniocentesis between July 2004 and July 2009. The outcomes of the cases in each group were compared with regard to the extension of pregnancy period, reasons for delivery, perinatal complications, stage of pathological CAM and funisitis (FUN), neonatal serum IgM concentration, mortality, and morbidity. RESULTS: The incidences of pathological CAM and FUN were significantly lower in Group B than in Group A. The concentration of neonatal serum IgM was also significantly lower in Group B than in Group A. CONCLUSIONS:
|
Authors | Azusa Shinjo, Katsufumi Otsuki, Maki Sawada, Hajime Ota, Mayumi Tokunaka, Tomohiro Oba, Ryu Matsuoka, Takashi Okai |
Journal | Archives of gynecology and obstetrics
(Arch Gynecol Obstet)
Vol. 286
Issue 2
Pg. 337-45
(Aug 2012)
ISSN: 1432-0711 [Electronic] Germany |
PMID | 22446734
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Immunoglobulin M
- Tocolytic Agents
- Leukocyte Elastase
|
Topics |
- Adult
- Amniocentesis
- Cesarean Section
- Chorioamnionitis
(diagnosis)
- Female
- Fetal Membranes, Premature Rupture
(drug therapy, surgery, therapy)
- Fetal Mortality
- Humans
- Immunoglobulin M
(blood)
- Infant, Newborn
- Labor, Induced
- Leukocyte Elastase
(analysis)
- Oligohydramnios
(diagnosis)
- Pregnancy
- Pregnancy Complications, Infectious
(diagnosis)
- Pregnancy Outcome
- Pregnancy Trimester, Third
- Retrospective Studies
- Tocolytic Agents
(therapeutic use)
|